C57BL mice (Fv_l b) develop a severe immunodeficiency disease following inoculation as adults with LP-BM5 murine leukemia virus (MuLV), a derivative of Duplan-Laterjet virus which contains B-tropic ecotropic and mink cell focus-inducing MuLVs and a putative defective genome which may be the proximal cause of disease. The stages of development of this disease were defined for C57BL mice on the basis of lymphadenopathy and splenomegaly; histopathological changes consistent with B-cell activation; and alterations in expression of cell surface antigens affected by proliferation of T cells, B cells, and macrophages. By using this disease profile as a standard, the response of adult mice of various inbred strains and selected F1 hybrids was compared. We show that although the strains which are highly sensitive are of the FV_1b genotype (i.e., permissive for B-tropic MuLVs), certain FV_lb strains, e.g., BALB/c and A/J, are resistant to murine acquired immunodeficiency syndrome, whereas certain Fv-1 strains (permissive for N-tropic MuLVs but restrictive for B-tropic MuLVs), notably P/N, BDP, and AKR, show moderate sensitivity and (C57BL/6 x CBA/N)F1 mice (Fv-1n/b and thus dually restrictive) are of relatively high susceptibility. The results of virus recovery tests suggest that apparently anomalous sensitivity, based on predicted Fv-1 restriction, may reflect MuLV induction and/or mutation to provide a helper virus for which the host is permissive.
were assayed for ecotropic MuLV by XC plaque tests (27) in SC-1 cells (7) , for MCF MuLV by focus induction tests in mink lung cells, directly or by the SC-1 UV-Mink assay (3, 9) , and for their ability to induce MAIDS in adult B6 mice. Virus pools used contained 103-7 to 105-6 XC PFU per ml and 102.8 to 104-7 MCF focus-forming units per ml. Virus recovery from mice was determined by infectious-center assays of mitomycin C-treated spleen cells (2, 3) .
Fv-1 and Rmcf typing. With the following exceptions, genotypes in Table 2 are based on published information (10, 22, 28) . Previously described procedures (10, 18, 22) were used to type P/N (Fv-1" Rmcf) and C57BL/Ks, RIIIS, and FVB (Fv-1b Rmcft) and to type ecotropic and MCF MuLV isolates for N/B tropism. BDP, previously typed as Fv-lb (28) , was found to be Fv-1" Rmcf'.
Histopathology. Samples of spleen, lymph nodes, thymus, lungs, liver, and kidneys were fixed in Tellyesniczky solution (10% neutral Formalin and 5% glacial acetic acid in 70% ethanol), sectioned, and stained with hematoxylin and eosin.
FACS. FACS assays of single-cell suspensions prepared from spleens were performed on a FACS 440 by established techniques (4, 11) . Antibodies used are detailed elsewhere (4, 11, 19) and included reagents to Thy-1, kappa light chain, immunoglobulin (IgG), Ly-5(B220), Ly-17, and Mac-1.
RESULTS
Although significant enlargement of spleen and lymph nodes may appear by 3 or 4 weeks after inoculation of susceptible mice with LP-BM5 MuLV, animals often survive for extended periods with extremely large peripheral lymph nodes and with spleen weights estimated to be in excess of 0.75 g. Death occurs, often suddenly, from several possible causes including respiratory failure due to infiltration of lungs by lymphoid cells and/or compression of air passages by enlarged mediastinal nodes, lymphoid infiltration of the kidneys, and, in a proportion of advanced cases, aggressive infiltration of the central nervous system (13) . Because of the unpredictable time of death, mortality data were not found to be useful for comparing patterns of disease induction. To establish criteria which would encompass time of onset, severity of response, and rate of progression, we evaluated the sensitive B6 strain during the first 3 months postinoculation for the following parameters: spleen weight, degree of lymphadenopathy, histopathological changes, and FACS profiles of splenic cell populations for cell size and reactivity with antibodies to cell surface antigens.
Gross and histopathological measures of disease progression. Early in the course of infection (2 to 3 weeks), histopathological changes were consistent with a severe immunological reaction, perhaps at least in part in response to infection with LP-BM5 ecotropic virus (M. Makino and H. C. Morse III, unpublished observations). In the spleen there was an increase in the size of follicles, although their spherical shape and location within periarterial lymphoid sheaths (PALS) were maintained ( Fig. la and b Infiltration of the lungs, kidneys, and liver occurred in advanced disease, seen first as perivascular cuffs of immunoblasts and plasmacytoid cells (Fig. lg) . As the disease progressed, extensive replacement of normal parenchyma was seen in the lungs, kidneys, and, to a lesser extent, liver. In very advanced cases, the central nervous system may be severely infiltrated by a similar process, initially involving the choroid plexus (13) .
FACS analysis of disease progression. Spleen cells from normal B6 mice or B6 mice infected 2 to 12 weeks previously with LP-BM5 MuLV were reacted with a series of fluorescein isothiocyanate-labeled antibodies to cell surface antigens and examined by FACS (Fig. 2 and data Immunol., in press). Similar changes in cell populations have been described for lymph nodes of mice with MAIDS (29) .
Stages of MAIDS. Similar stages of disease, from early to advanced, were definable by each of several criteria presented here and in other studies of MAIDS pathogenesis (19, 21 ; Klinman and Morse, in press). Table 1 compares the onset and progression of MAIDS in terms of gross findings, FACS profiles, and histopathology, defining a reactive, presumably prodromal phase and three stages of the disease. These stages are equivalent to those designating progressive changes in the humoral immune system which have been described for MAIDS (Klinman and Morse, in press). In applying these criteria for diagnosis, two points must be recognized. First, the time frame for disease progression given for B6 in Fig. 2 applies only to highly sensitive strains; a much more extended course is generally seen in less susceptible strains. Second, even among sensitive strains, individual mice with stage 3 disease may vary greatly in the degree of extralymphoid infiltration and FACS analysis of cell subsets in the spleen (19) .
Strain distribution of sensitivity to MAIDS and relation to Fv-1 genotype. The development of disease in a variety of inbred mouse strains inoculated with LP-BM5 MuLV was determined by gross and histopathological examination of mice killed that had obvious disease or those in groups terminated at either 6 to 7 or 8 to 20 months after infection ( Table 2 ). All mice of the highly susceptible strains, listed first, developed stage The same cells were also tested with antibodies specific for Ly-5(B220), ThB, Mac-1, and Ly-17 (not shown). In relation to FACS diagnoses listed in Table 1 Fig. 2 legend. (+) designates FACS profiles and frequencies of cell populations that differ slightly from normal and resemble changes seen in mice inoculated with LP-BM5 ecotropic MuLV (29) . ' High spleen weights (300 to 500 mg) in the reactive (R) category were found in old mice of resistant or partially resistant strains. Table 2 ).
The majority of diagnoses were of stage 2 or 3 disease, but the average latency was 192 days as compared with 99 days for B6 mice. Some mice developed visible peripheral lymphadenopathy at 2 or 3 months, which later decreased. When such regressor mice were killed at 6 to 13 months postinoculation, their hypoplastic lymph nodes were seen to have lost much of the lymphoid cell population, and all that remained was a hyperplastic stroma (Fig. lh) . Splenic changes were generally those of stage 2 or 3 disease, and occasional infiltration of nonlymphoid tissues was seen. Regression of lymphadenopathy was also frequently noted in strains P/N and BDP/J.
A possible basis for these unexpected sensitivities is shown in Table 4 , which presents the characterization of MuLVs isolated from certain Fv-1" and Fv-ln/b mice with MAIDS. For the two inoculated P/N mice tested, the ecotropic MuLVs recovered were N-tropic, as is virus recovered from normal, uninoculated P/N mice, suggesting that an endogenous ecotropic MuLV capable of establishing an efficiently spreading infection could supplant the helper function of the LP-BM5 ecotropic virus. Consistent with this suggestion is the development of MAIDS in 9 of 13 AKR mice inoculated when newborn with LP-BM5 MuLV (Table  2) . Virus recovery has not yet been studied, but abundant potential ecotropic MuLV would be available (26) . It is of interest that in addition to spleen and lymph node alterations consistent with MAIDS, the thymus, the primary site of spontaneous AKR T-cell lymphoma, was almost always greatly enlarged. Histopathological examination revealed that, in contrast to the predominance of small lymphocytes characteristic of AKR thymic lymphoma, the thymic medullae were filled with the population of immunoblasts, plasmacytoid cells, and plasma cells found in MAIDS (Fig. lf) . In AKR mice inoculated at 1 month of age, only thymic lymphoblastic lymphoma was detected (Table 2) , but further studies are required to determine the consistency and basis of this finding.
Virus recovery studies in the hybrids of strains B6 and CBA/N also provide evidence for a new helper virus, of different origin from those probably functioning in strains P/N and AKR. From all five mice with disease, the ecotropic MuLVs recovered were found to have dual N-B host range, as determined by demonstration of equivalent XC plaque titers in Fv-lJ, Fv-lb, and Fv-Jnlb tissue culture cells, even after high-dilution passage through Fv-JP and Fv-Jb cells to discriminate mixtures (data not shown). In only one case was B-tropic virus also recovered. Conversion to NB-tropism has been shown to occur on repeated passage of B-tropic viruses from BALB/c mice in Fv-J restrictive cells (12, 16) and is associated with point mutations in the p30 region of gag (5, 12, 23 The final strain shown in Table 4 is C57L, which lacks endogenous ecotropic MuLV sequences (17) . No ecotropic virus was recovered, either before or after development of disease, but N-tropic MCF MuLVs were detected in the mice with MAIDS, albeit at a low level.
DISCUSSION
This study establishes that the natural history of development of MAIDS is through progressive stages with B-cell activation and proliferation as a central feature, accompanied by a gradual decrease in the proportion of small T and B lymphocytes. The expansion of lymphoid tissue is primarily due to B cells in various stages of differentiation from immunoblasts to plasma cells (Fig. 1) . The initial source of these cells is the lymphoid follicle, which undergoes characteristic structural changes that appear to be irreversible and progressive, but the rate at which they occur varies with the susceptibility of the strain. Thus, in B6 mice the onset is rapid (a matter of 3 to 4 weeks after inoculation until the initial signs of disease can be detected). Successive stages follow at a fairly uniform rate, most animals having advanced lesions by 2 to 4 months. On the other hand, the less susceptible F1 progeny of crosses between B6 and CBA/N develop stage 2 or 3 disease in 3 to 10 months, and strains with more limited susceptibility may take a year or more to reach similar stages.
As noted in earlier studies of immunoglobulin isotype expression (21) , immunoglobulin heavy and light chain gene rearrangements (13) , and expressed immunoglobulin repertoires (Klinman and Morse, in press), the initial phase of B-cell proliferation in strains of high or more limited susceptibility is initially polyclonal. Polyclonality may give way to oligoclonality and then monoclonal disease as MAIDS progresses, but these changes cannot be distinguished on the basis of cytology (13) (Fig. 1) (Table 3) . Third, in the three instances of sensitivity to MAIDS displayed in genetic backgrounds inhibitory to B-tropic MuLV, we recovered MuLVs with host ranges allowing unrestricted replication (Table 4) . N-tropic ecotropic MuLV, presumably of endogenous origin, was recovered from P/N mice. From hybrids of B6 and CBA/N mice, NB-tropic ecotropic MuLVs were recovered with surprisingly high frequency, presumably representing mutants of LP-BM5 B-ecotropic MuLV that were in the original virus stocks or that were newly generated. For C57L mice, from which no ecotropic and only small amounts of MCF MuLV were recovered, one can speculate that C57L (H-2b) has an innate, possibly H-2-based susceptibility to MAIDS and that if a defective genome is rescued by even a rather poorly replicating N-tropic helper virus, disease will eventually ensue. In AKR mice, another example of a Fv-1'" strain with susceptibility to LP-BM5 MuLV-induced disease, high levels of N-tropic ecotropic virus are expressed shortly after birth (26) and N-tropic recombinant viruses of the MCF class are generated in the thymus by 6 months of age (9) . Taken together, these observations suggest that since Fv-J-controlled restriction is not absolute (22) The differences in strain sensitivity identified in this study will provide useful biological systems for examining the complex interplay between viruses and the immune system in the pathogenesis of MAIDS.
